The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Single-agent BRAF inhibitors have been largely ineffective in BRAF MT CRCs (19), despite activity in BRAF MT melanomas (20).”
From mTOR Inhibition Specifically Sensitizes Colorectal Cancers with KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1 (2014) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Research works printed but not linked: 28
- Comis RL, 1976, Cancer Treat Rep, 60, 165
- Atkins MB, 1999, J Clin Oncol, 17, 2105, 10.1200/JCO.1999.17.7.2105 · DOI
- Middleton MR, 2000, J Clin Oncol, 18, 158, 10.1200/JCO.2000.18.1.158 · DOI
- 10.1200/JCO.2006.06.0483 · DOI
- 10.1210/jc.2003-030838 · DOI
- 10.1038/sj.onc.1206739 · DOI
- 10.1093/jnci/95.8.625 · DOI
- Yuen ST, 2002, Cancer Res, 62, 6451
- 10.1038/sj.onc.1207061 · DOI
- Wang L, 2003, Cancer Res, 63, 5209
- 10.1136/gut.52.5.706 · DOI
- 10.1002/ijc.22071 · DOI
- 10.1093/jnci/95.6.484 · DOI
- 10.1200/JCO.2008.18.8623 · DOI
- Kimura ET, 2003, Cancer Res, 63, 1454
- 10.1073/pnas.0711741105 · DOI · Paper page
- 10.1186/1479-5876-8-39 · DOI
- 10.1097/00000421-198212000-00014 · DOI
- 10.1038/nrd1496 · DOI
- 10.1016/j.cell.2009.12.040 · DOI
- 10.1038/nature08902 · DOI
- 10.1038/nature08833 · DOI
- 10.1158/0008-5472.CAN-04-1443 · DOI
- 10.1038/sj.bjc.6603291 · DOI
- 10.1200/JCO.2007.14.8288 · DOI
- 10.1200/JCO.2007.15.7636 · DOI
- 10.1056/NEJMoa050092 · DOI · Paper page
- 10.1200/JCO.2008.21.7695 · DOI
Cited by
Sorted by citations
Items 101–111 of 111
Sale, M. J., & Cook, S. J. (2013) · Biochemical Journal · doi:10.1042/bj20121212 · Cited by 58
Martin, S., Dudek-Perić, A. M., Maes, H., Garg, A. D., Gabrysiak, M., Demirsoy, S., Swinnen, J. V., & Agostinis, P. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.003 · Cited by 54
Taking advantage of drug resistance, a new approach in the war on cancer
Wang, L., & Bernards, R. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0647-7 · Cited by 53
Seip, K., Fleten, K. G., Barkovskaya, A., Nygaard, V., Haugen, M. H., Engesæter, B. Ø., Mælandsmo, G. M., & Prasmickaite, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7671 · Cited by 41
The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis
Peres, J., Mowla, S., & Prince, S. (2015) · Oncotarget · doi:10.18632/oncotarget.2782 · Cited by 40
Nucleotide excision repair deficiency in melanoma in response to UVA
Murray, H. C., Maltby, V. E., Smith, D. W., & Bowden, N. A. (2015) · Experimental Hematology & Oncology · doi:10.1186/s40164-016-0035-4 · Cited by 28
BRAF V600E-dependent role of autophagy in uveal melanoma
Zhao, Y., Wang, W., Min, I., Wyrwas, B., Moore, M., Zarnegar, R., & Fahey, T. J. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2317-y · Cited by 26
Wu, X., Yu, J., Yan, J., Dai, J., Si, L., Chi, Z., Sheng, X., Cui, C., Ma, M., Tang, H., et al. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1435221 · Cited by 25
Saturno, G., Lopes, F., Niculescu-Duvaz, I., Niculescu-Duvaz, D., Zambon, A., Davies, L., Johnson, L., Preece, N., Lee, R., Viros, A., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.10.483 · Cited by 21
Self-citationWheler, J., Falchook, G., Tsimberidou, A. M., Hong, D., Naing, A., Piha-Paul, S., Chen, S. S., Heymach, J., Fu, S., Stephen, B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1028 · Cited by 17
The role of systemic and targeted therapies in brain metastases
Franceschi, E., Bartolotti, M., Poggi, R., Battista, M. D., Palleschi, D., & Brandes, A. A. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.856760 · Cited by 7
Metadata
- Authors
- Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., & Chapman, P. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-08-26
- Volume
- 363
- Issue
- 9
- Pages
- 809-819
- ISSN
- 0028-4793
- 1533-4406
- PMC
- PMC3724529
- Cited by
- 3,103
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
